This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.

JMP Securities Hematology and Oncology Summit
Fireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET
Location: Virtual

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.91
-3.12 (-1.41%)
AAPL  260.51
-2.26 (-0.86%)
AMD  238.10
+0.07 (0.03%)
BAC  51.26
-0.26 (-0.50%)
GOOG  256.36
+5.02 (2.00%)
META  737.77
+4.50 (0.61%)
MSFT  522.60
+4.94 (0.95%)
NVDA  182.97
+1.81 (1.00%)
ORCL  275.92
+0.77 (0.28%)
TSLA  442.59
-0.01 (-0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.